Abstract
This article shows the lessons learned from clinical trials of a new neurorehabilitation therapy for cerebro-vascular accident (CVA) patients. The new therapy is based on the combination of a transcranial direct current stimulation (tDCS) strategy, a brain-machine interface (BMI) based on electroencephalographic signals, and a pedaling system. The new therapy was applied during five consecutive days to six CVA patients with motor limitations in their right lower limb that are in the subacute phase. In this article, not only the clinical results are presented, but also the experiences and challenges of performing clinical trials with patients are described, which can be of great interest for future researchers that are planning to evaluate BMIs and tDCS systems with patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
